Literature DB >> 6124312

Immunoreactive somatostatin in catecholamine-producing extra-adrenal paraganglioma.

H Saito, S Saito, T Sano, N Kagawa, K Hizawa, K Tatara.   

Abstract

A patient with catecholamine-producing extra-adrenal paraganglioma was found to have a high concentration of immunoreactive somatostatin (IR-SRIF) in the peripheral blood plasma (47.0 pg/ml, normal; 13.3 +/- 5.3 pg/ml, mean +/- SD). After removal of the tumor, the plasma SRIF level fell within normal range (8.7 pg/ml). In the resected tumor, a considerable amount of IR-SRIF (71.0 ng/g wet weight)( was also detected and SRIF-positive tumor cells were demonstrated by the immunoperoxidase technique. Chromatographic analysis of an extract of the tumor showed the presence of two IR-SRIF components of large molecular size besides a component consistent with authentic tetradecapeptide SRIF (SRIF 14), and one of these had the same molecular size as octacosapeptide SRIF (SRIF 28). This seems to be the first report of a catecholamine-producing extra-adrenal paraganglioma that produces IR-SRIF with molecular heterogeneity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6124312     DOI: 10.1002/1097-0142(19820801)50:3<560::aid-cncr2820500329>3.0.co;2-i

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Immunohistochemical study of pheochromocytomas. An investigation of methionine-enkephalin, vasoactive intestinal peptide, somatostatin, corticotropin, beta-endorphin, and calcitonin in 16 tumors.

Authors:  J Hassoun; G Monges; P Giraud; J F Henry; C Charpin; H Payan; M Toga
Journal:  Am J Pathol       Date:  1984-01       Impact factor: 4.307

2.  Immunoreactive somatostatin in Warthin's tumor.

Authors:  Y Hayashi; H Saito; S Saito; T Yanagawa; H Yoshida; Y Yura; M Sato
Journal:  Am J Pathol       Date:  1986-05       Impact factor: 4.307

3.  Somatostatin-secreting Pheochromocytoma Mimicking Insulin-dependent Diabetes Mellitus.

Authors:  Hiroyuki Hirai; Sanae Midorikawa; Shinichi Suzuki; Hironobu Sasano; Tsuyoshi Watanabe; Hiroaki Satoh
Journal:  Intern Med       Date:  2016-10-15       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.